European Medicines Agency’s data protection notice for the use of EMA Authentication Services and Microsoft Entra ID
Records of data processing activity for EMA Authentication Services and Microsoft Entra ID
Human medicines European public assessment report (EPAR): Qdenga, dengue tetravalent vaccine (live, attenuated), Date of authorisation: 05/12/2022, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Tyruko, natalizumab, Date of authorisation: 22/09/2023, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Paxlovid, nirmatrelvir,ritonavir, Date of authorisation: 28/01/2022, Revision: 28, Status: Authorised
Human medicines European public assessment report (EPAR): Trixeo Aerosphere, formoterol,glycopyrronium bromide,budesonide, Date of authorisation: 09/12/2020, Revision: 7, Status: Authorised
CHMP PROM minutes for the meeting on 14 April 2025
Records of data processing activity for mail management
Minutes of the PRAC meeting 2-5 June 2025
QRD PSUR annex IV template